ATE464894T1 - Zusammensetzungen zur verbesserung von attention deficient hyperactivity disorder (adhd) - Google Patents

Zusammensetzungen zur verbesserung von attention deficient hyperactivity disorder (adhd)

Info

Publication number
ATE464894T1
ATE464894T1 AT01963497T AT01963497T ATE464894T1 AT E464894 T1 ATE464894 T1 AT E464894T1 AT 01963497 T AT01963497 T AT 01963497T AT 01963497 T AT01963497 T AT 01963497T AT E464894 T1 ATE464894 T1 AT E464894T1
Authority
AT
Austria
Prior art keywords
hyperactivity disorder
adhd
compositions
improving attention
attention deficient
Prior art date
Application number
AT01963497T
Other languages
English (en)
Inventor
Tomoko Kumagai
Makoto Ozeki
Tsutomu Okubo
Lekh Raj Juneja
Original Assignee
Taiyo Kagaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku Kk filed Critical Taiyo Kagaku Kk
Application granted granted Critical
Publication of ATE464894T1 publication Critical patent/ATE464894T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01963497T 2001-06-06 2001-09-07 Zusammensetzungen zur verbesserung von attention deficient hyperactivity disorder (adhd) ATE464894T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001171342A JP4812968B2 (ja) 2001-06-06 2001-06-06 注意欠陥多動性障害改善用組成物
PCT/JP2001/007763 WO2002100393A1 (fr) 2001-06-06 2001-09-07 Compositions destinees a ameliorer les troubles de manque d'attention/d'hyperactivite

Publications (1)

Publication Number Publication Date
ATE464894T1 true ATE464894T1 (de) 2010-05-15

Family

ID=19013123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01963497T ATE464894T1 (de) 2001-06-06 2001-09-07 Zusammensetzungen zur verbesserung von attention deficient hyperactivity disorder (adhd)

Country Status (11)

Country Link
US (1) US20060004026A1 (de)
EP (1) EP1393725B1 (de)
JP (1) JP4812968B2 (de)
KR (1) KR100519574B1 (de)
CN (1) CN1212836C (de)
AT (1) ATE464894T1 (de)
AU (1) AU2001284470B2 (de)
CA (1) CA2417837C (de)
DE (1) DE60141918D1 (de)
MX (1) MXPA03001060A (de)
WO (1) WO2002100393A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5005879B2 (ja) * 2004-02-18 2012-08-22 太陽化学株式会社 抗ストレス及びリラックス用組成物
WO2006061097A1 (en) * 2004-12-08 2006-06-15 Unilever Plc Food or beverage product comprising theanine and caffeine for enhancing mental alertness
US8945655B2 (en) * 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
US20090155420A1 (en) * 2007-12-12 2009-06-18 Conopco, Inc., D/B/A Unilever Food product with stabilized non-protein amino acids
KR100945462B1 (ko) * 2008-03-27 2010-03-05 주식회사 하이리빙 중금속의 체내 흡수 억제 및 체외 배출에 효과가 있는 식물성 식품조성물 및 이를 포함하는 건강식품
PL2343987T3 (pl) * 2008-11-11 2013-05-31 Unilever Nv Herbaciana kompozycja
CN102526347B (zh) * 2012-03-14 2014-12-17 上海善力健保健食品有限公司 一种具有改善记忆及脑功能保健品及制作方法
CN102755490B (zh) * 2012-07-03 2013-10-23 杨振刚 九香散加味治疗帕金森病
JP7037161B2 (ja) * 2016-07-07 2022-03-16 株式会社東洋新薬 経口組成物
CN110237062A (zh) * 2019-07-10 2019-09-17 吉林农业大学 一种以葡萄糖胺为调节剂的能够增强注意力的制剂
CN111034761A (zh) * 2019-12-23 2020-04-21 江西普正制药股份有限公司 一种杜仲饼干及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0873350A (ja) * 1994-09-06 1996-03-19 Itouen:Kk 脳機能改善剤、食品及び飲料
JP4627813B2 (ja) * 1995-06-27 2011-02-09 太陽化学株式会社 テアニン含有組成物
JPH0940568A (ja) * 1995-07-31 1997-02-10 Itouen:Kk カフェイン興奮作用抑制剤
US5869528A (en) * 1997-07-22 1999-02-09 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutical method for the treatment of attention-deficit/hyperactive disorders
CA2320368C (en) * 1998-02-23 2007-08-21 Taiyo Kagaku Co., Ltd. Composition comprising theanine
US6132724A (en) * 1998-04-29 2000-10-17 City Of Hope National Medical Center Allelic polygene diagnosis of reward deficiency syndrome and treatment
JP4669095B2 (ja) * 1999-07-19 2011-04-13 太陽化学株式会社 ペットの問題行動抑制組成物
US6520921B1 (en) * 2000-06-20 2003-02-18 Eastman Kodak Company Method for determining attention deficit hyperactivity disorder (ADHD) medication dosage and for monitoring the effects of (ADHD) medication
JP5300167B2 (ja) * 2001-08-24 2013-09-25 太陽化学株式会社 気分障害治療用組成物
US7455002B2 (en) * 2004-12-23 2008-11-25 The Goodyear Tire & Rubber Company Method for cutting elastomeric materials and the article made by the method

Also Published As

Publication number Publication date
JP2002363074A (ja) 2002-12-18
KR100519574B1 (ko) 2005-10-07
MXPA03001060A (es) 2003-05-27
CA2417837A1 (en) 2003-01-29
CN1449283A (zh) 2003-10-15
AU2001284470B2 (en) 2004-06-03
EP1393725A4 (de) 2006-03-08
JP4812968B2 (ja) 2011-11-09
KR20030022366A (ko) 2003-03-15
CA2417837C (en) 2009-08-04
EP1393725B1 (de) 2010-04-21
DE60141918D1 (de) 2010-06-02
US20060004026A1 (en) 2006-01-05
CN1212836C (zh) 2005-08-03
WO2002100393A1 (fr) 2002-12-19
EP1393725A1 (de) 2004-03-03

Similar Documents

Publication Publication Date Title
DE50109347D1 (de) Weichkapseln enthaltend Polymerisate von Vinylestern und Polyethern, deren Verwendung und Herstellung
WO2003088923A3 (en) Methods of treating ileus
HRP20041071A2 (en) Methods of treating hepatitis
DE60141918D1 (de) Zusammensetzungen zur verbesserung von attention deficient hyperactivity disorder (adhd)
ATE533365T1 (de) Herabsetzung von tabakbestandteilen
IL220043A0 (en) Methods for producing ??-galactosidase a compositions
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
ATE365703T1 (de) Substituierte 1,3-diphenylprop-2-en-1-on derivate,deren herstellung und anwendungen
AR032394A1 (es) Una composicion oral.
CA2412708A1 (en) Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
MXPA04005517A (es) Composiciones farmaceuticas bajo forma de gel o solucion a base de dihidrotestosterona, su metodo de preparacion y sus usos.
BR0313792A (pt) Utilização de proteìna de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
TR200202175T1 (tr) Hücrelerin biyoenerji metabolizmasında bulunan biyokimyasal bileşiklerin kompozisyonları
BR0201862A (pt) Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos
DE50102725D1 (de) Verfahren zur Herstellung von Ethanolaminen
DE60231149D1 (de) Zusammensetzungen mit hochgenauer dna-polymerase und verwendungen dafür
DE60230823D1 (de) L-cystein herstellendes Bakterium und Verfahren zur Herstellung von L-cystein
ATE363890T1 (de) Kationische polymerisate und deren verwendung in kosmetischen formulierungen
EP1572168A4 (de) Anti-infarkt-moleküle
DE50200022D1 (de) Mittel zur dauerhaften Verformung von menschlichen Haaren
ATE310734T1 (de) Verfahren zur herstellung von n-substituierten 2, 6-dialkylmorpholinen
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
ATE296126T1 (de) Gelenkimplantat sowie verfahren zum herstellen eines solchen
EA200400764A1 (ru) 1,3-диарилпроп-2-ен-1-оны, композиция на их основе и применение
DE50214566D1 (de) Bioanalytische Messverfahren zur Bestimmung von Katalasen und Peroxidasen, deren Konjugaten, Substraten, Aktivatoren, und Inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties